In Brief: Mallinckrodt
This article was originally published in The Gray Sheet
Mallinckrodt: Integration of the firm's Nellcor Puritan Bennett respiratory care acquisition, which closed in August, "is progressing well" and will largely be complete by the end of June, the firm reports Jan. 22. In preparing to take the next step to "strategically reposition the company with a single focus on its healthcare business," Mallinckrodt is "starting to explore" the divestiture of its $335 mil.-a-year industrial specialty chemicals business, and also is pursuing divestiture of an NPB aerospace equipment unit that makes oxygen equipment, passenger service units and video systems for the aerospace industry...
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.